비교리스트

 카트 문의
시장보고서
상품코드
1659425

세계의 차세대 시퀀싱(NGS) 샘플 조제 시장

Next Generation Sequencing (NGS) Sample Preparation
발행일: | 리서치사: Global Industry Analysts, Inc. | 페이지 정보: 영문 88 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 차세대 시퀸서(NGS) 샘플 조제 시장은 2030년까지 105억 달러에 달할 전망

2024년에 39억 달러로 추정되는 세계의 차세대 시퀸서(NGS) 샘플 조제 시장은 2024-2030년에 CAGR 18.2%로 성장하며, 2030년에는 105억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 시약·소모품은 CAGR 19.7%를 기록하며, 분석 기간 종료시에는 69억 달러에 달할 것으로 예측됩니다. 워크스테이션 분야의 성장률은 분석 기간 중 CAGR 15.5%로 추정됩니다.

미국 시장은 11억 달러, 중국은 CAGR 17.0%로 성장할 것으로 예측

미국의 차세대 시퀸서(NGS) 샘플 조제 시장은 2024년에 11억 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 16억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년의 CAGR은 17.0%입니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 16.0%와 15.2%로 예측됩니다. 유럽에서는 독일이 CAGR 약 13.0%로 성장할 것으로 예측됩니다.

세계의 차세대 시퀸서(NGS) 샘플 조제 시장 - 주요 동향과 촉진요인 정리

차세대 시퀀싱(NGS) 샘플 조제는 유전체학을 어떻게 발전시킬 것인가?

차세대 염기서열 분석(NGS) 샘플 조제는 연구, 임상 진단 및 맞춤 의료를 위한 DNA 및 RNA의 정확한 분석을 가능하게 하는 유전체 시퀀싱 프로세스의 중요한 단계입니다. 이 과정에는 DNA/RNA 추출, 라이브러리 준비, 표적 농축이 포함되며, 이 모든 과정은 고품질 시퀀싱 결과를 얻기 위해 필수적이며, NGS 샘플 조제는 자동화, 멀티플렉싱, 단일 세포 분석과 같은 기술 혁신으로 크게 발전하여 보다 빠르고 정확한 유전체 분석이 가능해졌습니다. 유전체학이 질병, 의약품 개발 및 집단 유전학에 대한 이해에 필수적인 요소로 자리 잡으면서 효율적인 시료 준비는 NGS 기술의 잠재력을 최대한 활용하기 위해 필수적입니다.

NGS 샘플 조제 시장의 주요 부문은?

주요 제품으로는 시약, 키트, 장비, 소모품이 있으며, 시약 및 키트는 라이브러리 준비와 표적 농축에 자주 사용되므로 시장을 독점하고 있습니다. 워크플로우에는 DNA 추출, 라이브러리 준비, 라이브러리 준비, 표적 농축이 있으며, 라이브러리 준비가 가장 큰 부문입니다. 주요 최종사용자로는 학술연구기관, 병원, 제약회사, 임상 실험실 등이 있으며, 이들은 모두 유전체 연구 수행, 맞춤 치료법 개발, 유전자 질환 진단을 위해 NGS 샘플 전처리를 사용하고 있습니다.

NGS 샘플 조제는 각 분야에서 어떻게 채택되고 있는가?

학술연구기관은 NGS 시료 준비의 가장 큰 사용자이며, 유전체 연구, 유전자 발현 연구, 바이오마커 탐색에 활용하고 있습니다. 병원과 임상검사실은 NGS 시료 전처리를 통해 유전질환 진단, 감염성 질환 검출, 개인별 맞춤 치료 계획 수립에 활용하고 있습니다. 제약회사는 유전자 표적 발굴, 신약 개발, 임상시험에 활용하고 있으며, 유전체 데이터는 약효 분석에 중요한 역할을 하고 있습니다. 집단 유전학 및 정밀의료에 대한 관심이 높아지면서 유전자 분석을 위해 대규모 염기서열 분석이 필요한 정부 지원 유전체 프로젝트와 바이오뱅크에서 NGS 시료 조제가 더욱 활발하게 사용되고 있습니다.

NGS 시료 준비 시장의 성장을 가속하는 요인은 무엇인가?

차세대 시퀀싱 샘플 조제 시장의 성장은 질병 연구, 맞춤형 의료, 의약품 개발에서 유전체학에 대한 수요 증가 등 여러 요인에 의해 주도되고 있습니다. 자동화 및 다중화 기술의 발전으로 시료 준비의 효율성과 정확성이 향상되어 전체 NGS 워크플로우의 속도가 빨라졌습니다. 유전적 인사이트에 크게 의존하는 정밀의료의 부상으로 첨단 시료 준비 기술의 필요성이 더욱 커지고 있습니다. 유전체 연구에 대한 정부 구상과 자금 지원은 임상 유전체학의 확대와 함께 시장 성장에 기여하고 있습니다. 암 진단, 희귀질환 진단, 감염성 질환 모니터링에 NGS의 사용이 증가함에 따라 효율적인 시료 준비 솔루션에 대한 수요도 증가하고 있습니다.

부문

제품 유형(시약·소모품, 워크스테이션), 워크플로우(반자동 라이브러리 조제, NGS 라이브러리 조제 키트, 자동 라이브러리 조제, 클론 증폭), 용도(종양학, 소비자 유전체학, 군유전체학, 역학·연구개발, 농업유전체학·과학 수사, HLA 타이핑·면역계 모니터링, 기타 용도), 최종 용도(학술연구, 임상 연구, 병원·진료소, 제약·바이오테크놀러지 기업, 기타 최종 용도)

조사 대상 기업의 예(주목 합계 32사)

  • Agilent Technologies
  • Beckman Coulter(A Subsidiary of Danaher)
  • Becton, Dickinson and Company
  • Berry Genomics
  • BGI
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • Macrogen
  • New England Biolabs, Inc.
  • Novo Gene
  • Nugen Technologies, Inc.
  • Oxford Gene Technology
  • Oxford Nanopore Technologies
  • Pacific Biosciences of California, Inc.
  • Perkinelmer, Inc.
  • Qiagen N.V
  • Raindance Technologies, Inc.
  • Swift Biosciences Inc.
  • Thermo Fisher
  • WuXi AppTec

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장의 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

KSA 25.03.07

Global Next Generation Sequencing (NGS) Sample Preparation Market to Reach US$10.5 Billion by 2030

The global market for Next Generation Sequencing (NGS) Sample Preparation estimated at US$3.9 Billion in the year 2024, is expected to reach US$10.5 Billion by 2030, growing at a CAGR of 18.2% over the analysis period 2024-2030. Reagents & Consumables, one of the segments analyzed in the report, is expected to record a 19.7% CAGR and reach US$6.9 Billion by the end of the analysis period. Growth in the Workstations segment is estimated at 15.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.1 Billion While China is Forecast to Grow at 17.0% CAGR

The Next Generation Sequencing (NGS) Sample Preparation market in the U.S. is estimated at US$1.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2030 trailing a CAGR of 17.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 16.0% and 15.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.0% CAGR.

Global Next Generation Sequencing (NGS) Sample Preparation Market - Key Trends and Drivers Summarized

How Is Next Generation Sequencing (NGS) Sample Preparation Evolving Genomics?

Next Generation Sequencing (NGS) Sample Preparation is a crucial step in the genomic sequencing process, enabling the accurate analysis of DNA and RNA for research, clinical diagnostics, and personalized medicine. This process involves DNA/RNA extraction, library preparation, and target enrichment, all of which are critical for obtaining high-quality sequencing results. NGS sample preparation has advanced significantly with innovations such as automation, multiplexing, and single-cell analysis, allowing for faster and more precise genomic analysis. As genomics becomes integral to understanding diseases, drug development, and population genetics, efficient sample preparation is essential for unlocking the full potential of NGS technologies.

What Are the Key Segments in the NGS Sample Preparation Market?

Key products include reagents, kits, instruments, and consumables, with reagents and kits dominating the market due to their frequent use in library preparation and target enrichment. In terms of workflow, the market covers DNA extraction, library preparation, and target enrichment, with library preparation being the largest segment. Major end-users include academic research institutions, hospitals, pharmaceutical companies, and clinical laboratories, all of which use NGS sample preparation to conduct genomic studies, develop personalized therapies, and diagnose genetic disorders.

How Is NGS Sample Preparation Being Adopted Across Sectors?

Academic research institutions are the largest users of NGS sample preparation, utilizing it for genomic research, gene expression studies, and biomarker discovery. Hospitals and clinical laboratories leverage NGS sample preparation for diagnosing genetic disorders, detecting infectious diseases, and guiding personalized treatment plans. Pharmaceutical companies use it to identify genetic targets, develop new drugs, and conduct clinical trials, where genomic data plays a critical role in drug efficacy analysis. The growing interest in population genetics and precision medicine is further driving the adoption of NGS sample preparation in government-funded genomic projects and biobanks, which require large-scale sequencing for genetic analysis.

What Factors Are Driving the Growth in the NGS Sample Preparation Market?

The growth in the Next Generation Sequencing Sample Preparation market is driven by several factors, including the increasing demand for genomics in disease research, personalized medicine, and drug development. Technological advancements in automation and multiplexing have improved the efficiency and accuracy of sample preparation, enhancing the overall speed of NGS workflows. The rise of precision medicine, which relies heavily on genetic insights, has further fueled the need for advanced sample preparation techniques. Government initiatives and funding for genomic research, coupled with the expansion of clinical genomics, are contributing to market growth. The increasing use of NGS in cancer diagnostics, rare disease detection, and infectious disease monitoring is also driving the demand for efficient sample preparation solutions.

SCOPE OF STUDY:

The report analyzes the Next Generation Sequencing (NGS) Sample Preparation market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Reagents & Consumables, Workstations); Workflow (Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation, Clonal Amplification); Application (Oncology, Consumer Genomics, Metagenomics, Epidemiology & Drug Development, Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications); End-Use (Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 32 Featured) -

  • Agilent Technologies
  • Beckman Coulter (A Subsidiary of Danaher)
  • Becton, Dickinson and Company
  • Berry Genomics
  • BGI
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • Macrogen
  • New England Biolabs, Inc.
  • Novo Gene
  • Nugen Technologies, Inc.
  • Oxford Gene Technology
  • Oxford Nanopore Technologies
  • Pacific Biosciences of California, Inc.
  • Perkinelmer, Inc.
  • Qiagen N.V
  • Raindance Technologies, Inc.
  • Swift Biosciences Inc.
  • Thermo Fisher
  • WuXi AppTec

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Next Generation Sequencing (NGS) Sample Preparation - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for High-Throughput Sequencing Spurs Growth in NGS Sample Preparation Market
    • Technological Advancements in Automation and Library Preparation Kits Strengthen Business Case for Adoption
    • Growing Focus on Precision Medicine and Genomic Research Expands Addressable Market for NGS Sample Preparation
    • Expansion of NGS Sample Preparation in Academic Research and Clinical Laboratories Fuels Market Growth
    • Increasing Adoption of NGS Sample Preparation in Cancer Genomics, Infectious Disease, and Genetic Disorders Expands Market Opportunities
    • Technological Innovations in Single-Cell Sequencing and RNA Sequencing Propel Market Expansion
    • Rising Focus on Reducing Turnaround Time and Cost per Sample Drives Demand for NGS Sample Preparation
    • Growing Use of NGS Sample Preparation in Pharmacogenomics and Drug Development Expands Market Potential
    • Technological Advancements in Multiplex PCR, Target Enrichment, and Library Construction Propel Market Growth
    • Increasing Focus on Integrating NGS Sample Preparation with Bioinformatics Pipelines Drives Adoption
    • Rising Demand for NGS Sample Preparation in Plant Genomics, Microbiome, and Epigenetics Research Strengthens Global Market
    • Expansion of NGS Sample Preparation in Liquid Biopsy and Minimal Residual Disease Testing Expands Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Semi-Automated Library Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World 6-Year Perspective for Semi-Automated Library Preparation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for NGS Library Preparation Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 4: World 6-Year Perspective for NGS Library Preparation Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Automated Library Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World 6-Year Perspective for Automated Library Preparation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Clonal Amplification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World 6-Year Perspective for Clonal Amplification by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 10: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World 6-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Consumer Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World 6-Year Perspective for Consumer Genomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 15: World Recent Past, Current & Future Analysis for Metagenomics, Epidemiology & Drug Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 16: World 6-Year Perspective for Metagenomics, Epidemiology & Drug Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Agrigenomics & Forensics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World 6-Year Perspective for Agrigenomics & Forensics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for HLA Typing / Immune System Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 20: World 6-Year Perspective for HLA Typing / Immune System Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 21: World Recent Past, Current & Future Analysis for Academic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 22: World 6-Year Perspective for Academic Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Clinical Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World 6-Year Perspective for Clinical Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 26: World 6-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 27: World Recent Past, Current & Future Analysis for Pharma & Biotech Entities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 28: World 6-Year Perspective for Pharma & Biotech Entities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 31: World Next Generation Sequencing (NGS) Sample Preparation Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 35: World 6-Year Perspective for Reagents & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 36: World Recent Past, Current & Future Analysis for Workstations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 37: World 6-Year Perspective for Workstations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Next Generation Sequencing (NGS) Sample Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2025 & 2030
    • TABLE 40: USA Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: USA 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2025 & 2030
    • TABLE 42: USA Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: USA 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2025 & 2030
  • CANADA
    • TABLE 46: Canada Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Canada 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2025 & 2030
    • TABLE 48: Canada Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Canada 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2025 & 2030
    • TABLE 52: Canada Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Canada 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2025 & 2030
  • JAPAN
    • Next Generation Sequencing (NGS) Sample Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 54: Japan Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Japan 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2025 & 2030
    • TABLE 58: Japan Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Japan 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2025 & 2030
    • TABLE 60: Japan Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Japan 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2025 & 2030
  • CHINA
    • Next Generation Sequencing (NGS) Sample Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2025 & 2030
    • TABLE 64: China Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: China 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2025 & 2030
    • TABLE 66: China Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: China 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2025 & 2030
  • EUROPE
    • Next Generation Sequencing (NGS) Sample Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 70: Europe Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Europe 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2025 & 2030
    • TABLE 72: Europe Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Europe 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2025 & 2030
    • TABLE 76: Europe Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 77: Europe 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 78: Europe Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Europe 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2025 & 2030
  • FRANCE
    • Next Generation Sequencing (NGS) Sample Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2025 & 2030
    • TABLE 82: France Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: France 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2025 & 2030
    • TABLE 84: France Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: France 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2025 & 2030
  • GERMANY
    • Next Generation Sequencing (NGS) Sample Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 88: Germany Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Germany 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2025 & 2030
    • TABLE 90: Germany Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Germany 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2025 & 2030
    • TABLE 94: Germany Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Germany 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2025 & 2030
  • ITALY
    • TABLE 96: Italy Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Italy 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2025 & 2030
    • TABLE 100: Italy Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Italy 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2025 & 2030
    • TABLE 102: Italy Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Italy 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2025 & 2030
  • UNITED KINGDOM
    • Next Generation Sequencing (NGS) Sample Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2025 & 2030
    • TABLE 106: UK Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 107: UK 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2025 & 2030
    • TABLE 108: UK Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 109: UK 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 112: Rest of Europe Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Rest of Europe 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2025 & 2030
    • TABLE 114: Rest of Europe Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Rest of Europe 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2025 & 2030
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Rest of Europe 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2025 & 2030
    • TABLE 118: Rest of Europe Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 119: Rest of Europe 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Next Generation Sequencing (NGS) Sample Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 120: Asia-Pacific Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 121: Asia-Pacific 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2025 & 2030
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2025 & 2030
    • TABLE 124: Asia-Pacific Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Asia-Pacific 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2025 & 2030
    • TABLE 126: Asia-Pacific Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Asia-Pacific 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 128: Rest of World Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of World 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2025 & 2030
    • TABLE 130: Rest of World Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 131: Rest of World 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2025 & 2030
    • TABLE 132: Rest of World Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 133: Rest of World 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2025 & 2030
    • TABLE 134: Rest of World Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of World 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2025 & 2030

IV. COMPETITION

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제